Tuan Huy NGUYEN, Liver cell and gene therapy expert, is a co-founder of GoLiver Therapeutics and was recruited in April 2017 as chairman and chief scientific officer (CSO) to develop an Advanced Therapy Medicinal Product (ATMP) based on human pluripotent stem cells for the treatment of severe liver failures. He previously headed an academic research group on gene and cell therapy for treating liver diseases (lentiviral vectors, genome editing with CRISPR/cas and ZFNs, pluripotent stem cells) and the GenoCellEdit platform at the INSERM UMR1064 unit – Center of Research in Transplantation & Immunology at Nantes University Hospital (France) from 2012 to 2017. In 2016, he was the chairman of the 21st NAT (Nantes Actualités Transplantation) “When Stem Cells Meet Immunology”. He was Deputy Editor of Current Gene Therapy journal and has published over 64 original publications in the field of cell and gene therapy. The Goliver Therapeutic project was awarded of the Grand Prize “pharmaceuticals and biotechnology” from the French Research Ministry in the national innovation start-up contest i-LAB and of the start West award, a contest for innovative start-ups in the France « Great West » (« Grand Ouest ») in 2016, and of the “Coup de Coeur” award of the Atlanpole forum in 2018.